Results 101 to 110 of about 4,501 (207)

Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after the unsuccessful therapy with systemic steroids. Our experience in 86 patients

open access: yesThe Egyptian Journal of Otolaryngology
Objective To determine the efficacy of salvage intratympanic corticosteroid therapy in patients with idiopathic sudden sensorineural hearing loss (ISSNHL) who exhibited an insufficient response to initial systemic corticosteroids. Material and methods In
Andres Gonzalez Fernandez   +6 more
doaj   +1 more source

Intratympanic gentamicin therapy for meniere’s disease

open access: yesIndian Journal of Otolaryngology and Head and Neck Surgery, 1997
Early attempts of topical therapy for Meniere's Disease by instillation of an aminoglycoside (150mg-4.2g of Streptomycin) was by Schuknecht in 19571 not surprisingly this was given up mainly due to the cochleotoxic effects of the drug resulting in an average 62% hearing loss in the 8 patients treated.
openaire   +3 more sources

Intratympanic gentamicin therapy for control of vertigo in unilateral Meniere's disease:a prospective, double-blind, randomized, placebo-controlled trial

open access: yes, 2008
Conclusions. Intratympanic application of gentamicin is a relatively safe and efficient treatment for the reduction of complaints of vertigo attacks associated with Meniere's disease.
Albers, Frans W. J.   +6 more
core   +1 more source

Systemic Steroid Versus Combined Systemic and Intratympanic Steroid Treatment for Sudden Sensorineural Hearing Loss

open access: yes, 2013
Objective: The aim of this study was to evaluate the effectiveness of oral steroid treatment versus combined oral and intratympanic dexamethasone injection for idiopathic sudden sensorineural hearing loss. Methods: This was a retrospective case review in

core   +1 more source

Intratympanic Gels for Inner Ear Disorders: A Scoping Review of Clinical Trials

open access: yes
ObjectiveIntratympanic injections are a safe, well tolerated procedure routinely performed by ENT's specialists. Intratympanic injections of gels have the potential to deliver therapeutics into the cochlea through the round window membrane prolonging the
Brotto, Davide, Greggio, Marco
core   +1 more source

Intratympanic corticosteroids for sudden sensorineural hearing loss

open access: yes, 2022
BACKGROUND: Idiopathic sudden sensorineural hearing loss (ISSNHL) is common, and defined as a sudden decrease in sensorineural hearing sensitivity of unknown aetiology.
Galbraith, Kevin   +10 more
core  

Comparative study between Intratympanic Steroid Injection and Intratympanic Platelet Rich Plasma (PRP) Injection in Sudden Sensorineural Hearing Loss (SSNHL) [PDF]

open access: yesAl-Azhar International Medical Journal
Background: Sudden sensorineural hearing loss (SSNHL) is a sudden, often unilateral hearing impairment with unclear causes. An intratympanic dexamethasone injection is a treatment option, delivering anti-inflammatory benefits directly to the inner ear ...
doaj   +1 more source

Intratympanic Membrane Congenital Cholesteatoma

open access: yesEar, Nose & Throat Journal, 2015
Hiroshi, Sakaida, Kazuhiko, Takeuchi
openaire   +2 more sources

Use of Intratympanic Dexamethasone as a Salvage Treatment in Idiopathic Sudden Hearing Loss

open access: yes, 2010
Objective: We aimed to assess effect of intratympanic dexamethasone treatment on hearing in the patients who did not respond to conventional systemic treatment of idiopathic sensorineural hearing loss (ISHL)
CEYLAN, ALPER   +6 more
core  

Home - About - Disclaimer - Privacy